Freeline Announces June 2022 Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
LONDON, July 01, 2022 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced that on June 30, 2022, the Company granted a newly hired employee non-statutory…